A detailed history of Mengis Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 5,552 shares of AMGN stock, worth $1.64 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
5,552
Previous 5,537 0.27%
Holding current value
$1.64 Million
Previous $1.73 Million 3.35%
% of portfolio
0.36%
Previous 0.36%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$309.38 - $337.38 $4,640 - $5,060
15 Added 0.27%
5,552 $1.79 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $32,843 - $39,913
-125 Reduced 2.21%
5,537 $1.73 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $33,608 - $40,570
125 Added 2.26%
5,662 $1.61 Million
Q4 2023

Feb 01, 2024

SELL
$255.7 - $288.46 $6,392 - $7,211
-25 Reduced 0.45%
5,537 $1.59 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $655 - $814
-3 Reduced 0.05%
5,562 $1.49 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $119,776 - $141,633
-559 Reduced 9.13%
5,565 $1.24 Million
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $41,996 - $51,187
-186 Reduced 2.95%
6,124 $1.48 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $90,695 - $115,239
-396 Reduced 5.91%
6,310 $1.66 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $33,669 - $37,972
-150 Reduced 2.19%
6,706 $1.51 Million
Q2 2022

Jul 19, 2022

SELL
$230.71 - $256.74 $21,917 - $24,390
-95 Reduced 1.37%
6,856 $1.67 Million
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $341,622 - $377,924
-1,558 Reduced 18.31%
6,951 $1.68 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $211,210 - $241,711
-1,062 Reduced 11.1%
8,509 $1.91 Million
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $10,613 - $12,435
-50 Reduced 0.52%
9,571 $2.04 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $99,972 - $110,911
428 Added 4.66%
9,621 $2.35 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $5,547 - $6,465
-25 Reduced 0.27%
9,193 $2.29 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $121,172 - $144,295
560 Added 6.47%
9,218 $2.12 Million
Q3 2020

Oct 29, 2020

SELL
$234.65 - $260.95 $20,883 - $23,224
-89 Reduced 1.02%
8,658 $2.2 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $4,730 - $6,080
-25 Reduced 0.28%
8,747 $2.11 Million
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $55,018 - $65,923
316 Added 3.74%
8,772 $1.7 Million
Q1 2019

May 06, 2019

BUY
$180.87 - $203.88 $8,139 - $9,174
45 Added 0.54%
8,456 $1.61 Million
Q3 2018

Nov 05, 2018

BUY
$185.29 - $208.89 $162,684 - $183,405
878 Added 11.66%
8,411 $1.74 Million
Q2 2018

Jul 24, 2018

BUY
$166.05 - $186.51 $31,881 - $35,809
192 Added 2.62%
7,533 $1.39 Million
Q1 2018

Apr 27, 2018

SELL
$169.43 - $198.0 $132,833 - $155,232
-784 Reduced 9.65%
7,341 $1.25 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $212,675 - $237,623
1,260 Added 18.35%
8,125 $1.41 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $1.15 Million - $1.31 Million
6,865
6,865 $1.28 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mengis Capital Management, Inc. Portfolio

Follow Mengis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.